50 related articles for article (PubMed ID: 38734662)
1. Thymic gene expression analysis reveals a potential link between HIF-1A and Th17/Treg imbalance in thymoma associated myasthenia gravis.
Altınönder İ; Kaya M; Yentür SP; Çakar A; Durmuş H; Yegen G; Özkan B; Parman Y; Sawalha AH; Saruhan-Direskeneli G
J Neuroinflammation; 2024 May; 21(1):126. PubMed ID: 38734662
[TBL] [Abstract][Full Text] [Related]
2. Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression.
Cebi M; Cakar A; Erdogdu E; Durmus-Tekce H; Yegen G; Ozkan B; Parman Y; Saruhan-Direskeneli G
J Neuroimmunol; 2023 Aug; 381():578129. PubMed ID: 37329662
[TBL] [Abstract][Full Text] [Related]
3. Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization.
Iacomino N; Scandiffio L; Conforti F; Salvi E; Tarasco MC; Bortone F; Marcuzzo S; Simoncini O; Andreetta F; Pistillo D; Voulaz E; Alloisio M; Antozzi C; Mantegazza R; De Pas TM; Cavalcante P
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979710
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase USP29 correlates RORγt expression and its association with thymoma myasthenia gravis.
Xia D; Pan L; Fu X; Meng Y; Li M; Wang W; Wang Z
Am J Transl Res; 2022; 14(12):8632-8639. PubMed ID: 36628242
[TBL] [Abstract][Full Text] [Related]
5. Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis.
Norata D; Peri M; Giammalva GR; Lupica A; Paolini F; Incorvaia L; Badalamenti G; Gristina V; Galvano A; Russo A; Iacopino DG; Silvestrini M; Bazan V; Brighina F; Di Stefano V
Diagnostics (Basel); 2023 Jan; 13(1):. PubMed ID: 36611440
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma.
Yasumizu Y; Ohkura N; Murata H; Kinoshita M; Funaki S; Nojima S; Kido K; Kohara M; Motooka D; Okuzaki D; Suganami S; Takeuchi E; Nakamura Y; Takeshima Y; Arai M; Tada S; Okumura M; Morii E; Shintani Y; Sakaguchi S; Okuno T; Mochizuki H
Nat Commun; 2022 Jul; 13(1):4230. PubMed ID: 35869073
[TBL] [Abstract][Full Text] [Related]
7. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Marx A; Chan JKC; Chalabreysse L; Dacic S; Detterbeck F; French CA; Hornick JL; Inagaki H; Jain D; Lazar AJ; Marino M; Marom EM; Moreira AL; Nicholson AG; Noguchi M; Nonaka D; Papotti MG; Porubsky S; Sholl LM; Tateyama H; Thomas de Montpréville V; Travis WD; Rajan A; Roden AC; Ströbel P
J Thorac Oncol; 2022 Feb; 17(2):200-213. PubMed ID: 34695605
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis.
Chen Y; Zhang XS; Wang YG; Lu C; Li J; Zhang P
Mol Immunol; 2021 May; 133():67-76. PubMed ID: 33636431
[TBL] [Abstract][Full Text] [Related]
9. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases.
Capone A; Volpe E
Front Immunol; 2020; 11():348. PubMed ID: 32226427
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients.
Lee MC; Hsiao TH; Chuang HN; Lee LW; Chi PL; Tsai HM; Mao CL; Hsu CP
Lung Cancer; 2020 Jan; 139():157-164. PubMed ID: 31809976
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.
Lefeuvre CM; Payet CA; Fayet OM; Maillard S; Truffault F; Bondet V; Duffy D; de Montpreville V; Ghigna MR; Fadel E; Mansuet-Lupo A; Alifano M; Validire P; Gossot D; Behin A; Eymard B; Berrih-Aknin S; Le Panse R
J Autoimmun; 2020 Jan; 106():102337. PubMed ID: 31594658
[TBL] [Abstract][Full Text] [Related]
13. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
[TBL] [Abstract][Full Text] [Related]
14. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
[TBL] [Abstract][Full Text] [Related]
15. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
16. CD4
Kohler S; Keil TOP; Hoffmann S; Swierzy M; Ismail M; Rückert JC; Alexander T; Meisel A
Clin Immunol; 2017 Jun; 179():40-46. PubMed ID: 28286113
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia Gravis.
Gilhus NE
N Engl J Med; 2016 Dec; 375(26):2570-2581. PubMed ID: 28029925
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
